Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.40 |
| ▸ | USP30 | Q70CQ3 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | PRKDC | P78527 | 1/20 | 0.37 |
| ▸ | SLC5A1 | P13866 | 11/20 | 0.37 |
| ▸ | PLAT | P00750 | 2/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30801850 | 0.88 | USP30 (0.39) | USP30HTR2AHTR2CHTR2BGRM5 | |
| SCHEMBL30801750 | 0.86 | PARP1 (0.39) | XDHUSP30PLATGRM5 | |
| SCHEMBL30801744 | 0.84 | NPC1 (0.38) | USP30HTR2AHTR2CHTR2BPLAT | |
| SCHEMBL30801805 | 0.83 | CRHBP (0.43) | USP30HTR2CPLATGRM5 | |
| SCHEMBL30801830 | 0.83 | CRHBP (0.43) | USP30HTR2CPLATGRM5 | |
| SCHEMBL23574047 | 0.82 | USP30 (0.53) | XDHUSP30PRKDC | |
| SCHEMBL30986840 | 0.82 | USP30 (0.53) | XDHUSP30PRKDC | |
| SCHEMBL23574049 | 0.82 | USP30 (0.53) | XDHUSP30PRKDC | |
| SCHEMBL30801748 | 0.81 | USP30 (0.39) | XDHUSP30HTR2CHTR2BPRKDC | |
| SCHEMBL30801848 | 0.81 | USP30 (0.39) | XDHUSP30HTR2CHTR2BPRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3793997-B1 | FUSED BICYCLIC COMPOUNDS USEFUL AS UBIQUITIN-SPECIFIC PEPTIDASE 30 INHIBITORS | FORMA THERAPEUTICS INC (US) | 2024-03-13 | — | — | EP | claimed |